Food
By Benjamin Chiou
Date: Monday 21 Aug 2023
(Sharecast News) - Berenberg has raised its target price for Glanbia after the Irish performance nutrition and food manufacturer's forecast-beating interim results last week, as strong margins make up for declining volumes.
By Iain Gilbert
Date: Thursday 29 Oct 2020
(Sharecast News) - Nutrition group Glanbia said on Thursday that year-to-date wholly-owned revenues and cash flows had improved despite the Covid-19 pandemic, leading it to launch a share buyback.
By Josh White
Date: Wednesday 12 Aug 2020
(Sharecast News) - Nutrition company Glanbia reported a "resilient" first half performance amid the Covid-19 pandemic on Wednesday, as adjusted earnings per share declined 17.2% at constant currencies to 31.05 euro cents (28p).
Morgan Stanley sees challenging 2019 for Glanbia | 15-Jan-2019 | ShareCast |
Glanbia to buy SlimFast for $350m | 11-Oct-2018 | ShareCast |
Glanbia to sell 60% stake in Irish dairy business | 26-Apr-2017 | ShareCast |
Glanbia completes acquisition of Body & Fit | 03-Apr-2017 | ShareCast |
Glanbia improves FY profit, proposes creation of... | 22-Feb-2017 | ShareCast |
Currency | Euro |
Share Price | 14.20 |
Change Today | -0.20 |
% Change | -1.39 % |
52 Week High | 16.60 |
52 Week Low | 9.10 |
Volume | 7,911 |
Shares Issued | 252.09m |
Market Cap | 3,579.61m |
Beta | 0.00 |
RiskGrade | 168 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 3 |
Buy | 6 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 10 |
Latest | Previous | |
---|---|---|
Interim | Final | |
Ex-Div | 21-Aug-25 | 20-Mar-25 |
Paid | 03-Oct-25 | 02-May-25 |
Amount | 17.20¢ | 23.33¢ |
Time | Volume / Share Price |
16:57 | 173 @ 14.27 |
17:13 | 240 @ 14.30 |
17:13 | 325 @ 14.18 |
14:59 | 0 @ 14.70 |
14:28 | 2 @ 14.30 |
You are here: research